ArticleiGIE : innovation, investigation and insights2024
The rate of biliary adverse events in duct-to-duct living donor liver transplant compared with deceased donor liver transplant.
Article in iGIE : innovation, investigation and insights, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Living donor liver transplantation (LDLT) allows for decreased listing-to-transplant time in patients with end-stage liver disease but has been noted to be associated with higher rates of biliary adverse events. The aim of this study was to assess the adverse events of LDLT and compare them versus those of deceased donor liver transplantation (DDLT) patients. Methods: We retrospectively reviewed patients having undergone duct-to-duct anastomosis LDLT at a single center from 2011 to 2020. Exclusion criteria included pediatric patients and LDLT with Roux-en-Y hepaticojejunostomy. Patients were then matched 1:1 with DDLT. Matching was performed by age, gender, etiology of liver disease, and Model for End-Stage Liver Disease score. Outcomes of interest included incidence of biliary strictures, bile leak, stricture recurrence rate, and the number of interventions required for stricture resolution. Results: Fifty patients with LDLT were matched to 50 patients with DDLT. Bile leak occurred in 14 (38%) patients in the LDLT group versus 5 (10%) patients in the DDLT group ( Conclusions: Patients who underwent LDLT were equally as likely to develop anastomotic strictures compared with DDLT. Duct-to-duct anastomosis LDLT should be frequently considered in patients with end-stage liver disease with favorable anatomy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.